The U.S. Food and Drug Administration this week gave its first ever nod for an anti-HIV drug, Truvada, to pharmaceutical firm Gilead Sciences.
Forfeiting our commons
The Lancet’s Series on Maternal and Child Undernutrition
President Obama's grand climate plan does not add up
Climate change can no longer be ignored
NGO demands withdrawal of Niyamgiri gram sabha notificatio